Engineering next-generation biologics for regenerative medicine and inflammatory disease.
Orion Biotech develops recombinant proteins, cell-based technologies, and translational biologics for dermatology, hair regeneration, metabolic disease, and tissue repair.
Technology Focus
- Recombinant protein engineering
- Mammalian cell expression
- Regenerative medicine
- Dermatology and hair biology
- Translational biologics
Research Pipeline
- Recombinant Human Type III Collagen
- SSD624 for seborrheic dermatitis
- Long-acting urate oxidase
- Hair follicle regeneration
- Additional biologics programs
Platform Capabilities
- Protein design and expression
- CHO cell expression
- Fermentation and purification
- Preclinical validation
- Translational development
Why Orion Biotech
- Scientist-led company
- Deep experience in skin, hair, and biologics
- Focus on clinically translatable technologies
- Open to collaboration, licensing, and co-development
Collaboration and licensing inquiries
We welcome discussions with research institutions, clinical partners, CDMO partners, distributors, and strategic investors.
Contact Us